Publication
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas
Maria Dimou, Sotirios G. Papageorgiou, Niki Stavroyianni, Eirini Katodritou, Maria Tsirogianni, Christina Kalpadakis, Anastasia Banti, Maria Arapaki, Theodoros Iliakis, Maria Bouzani, Eugenia Verrou, Emmanouil Spanoudakis, Stavroula Giannouli, Theodoros Marinakis, Evdokia Mandala, Despoina Mparmparousi, Sotirios Sachanas, Maria Dalekou‐Tsolakou, Eleftheria Hatzimichael, Chryssa Vadikolia, Vasiliki Violaki, Christos Poziopoulos, Pantelis Tsirkinidis, Sofia Chatzileontiadou, Elissavet Vervessou, Maria Ximeri, Anastasia Sioni, Pavlina Konstantinidou, Marie‐Christine Kyrtsonis, Marina P. Siakantaris, Maria K. Angelopoulou, Vassiliki Pappa, Kostas Konstantopoulos, Panayiotis Panayiotidis, Theodoros P. Vassilakopoulos
Hematological Oncology, March 2021, Wiley
DOI: 10.1002/hon.2842